Funding | Life Science Washington An independent, non-profit 501(c)(6) trade association serving the life sciences industry in the state of Washington. Tue, 13 May 2025 19:11:15 +0000 en-US hourly 1 https://wordpress.org/?v=6.8 https://lifesciencewa.org/wp-content/uploads/2020/10/cropped-LSW_favicon-1-32x32.png Funding | Life Science Washington 32 32 Seattle Startup CueZen Raises $5M for Personalized Health Coaching Software https://lifesciencewa.org/2025/05/13/seattle-startup-cuezen-raises-5m-for-personalized-health-coaching-software/ Tue, 13 May 2025 19:11:12 +0000 https://lifesciencewa.org/?p=13575 CueZen, a Seattle-based startup that sells software designed to boost personalized healthcare programs, raised $5 million in a round led by Point 72 Ventures. Founded in 2021, CueZen leverages AI and data from sensor-based devices to help people adhere to care plans and promote healthy habits. Customers include healthcare organizations such as Titan and Microport. […]

The post Seattle Startup CueZen Raises $5M for Personalized Health Coaching Software appeared first on Life Science Washington.

]]> CueZen, a Seattle-based startup that sells software designed to boost personalized healthcare programs, raised $5 million in a round led by Point 72 Ventures.

Founded in 2021, CueZen leverages AI and data from sensor-based devices to help people adhere to care plans and promote healthy habits.

Customers include healthcare organizations such as Titan and Microport. CueZen also sells to the Singapore government, which uses the software for its wellness programs.

CueZen CEO and co-founder Ankur Teredesai previously founded KenSci, a Seattle healthtech startup acquired by Tegria in 2021. He’s a longtime professor at the University of Washington.

The post Seattle Startup CueZen Raises $5M for Personalized Health Coaching Software appeared first on Life Science Washington.

]]> $600,000 in Awards Against Ovarian Cancer for Fred Hutch and University of Washington Researchers https://lifesciencewa.org/2025/04/22/600000-in-awards-against-ovarian-cancer-for-fred-hutch-and-universtiy-of-washington-researchers/ Tue, 22 Apr 2025 15:20:30 +0000 https://lifesciencewa.org/?p=13436 In 2023, the Rivkin Center partnered with the Andy Hill Cancer Research Endowment (CARE) Fund to fund $1M in grants for research institutions in Washington state to unlock answers in ovarian cancer. This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine respectively, have each […]

The post $600,000 in Awards Against Ovarian Cancer for Fred Hutch and University of Washington Researchers appeared first on Life Science Washington.

]]> In 2023, the Rivkin Center partnered with the Andy Hill Cancer Research Endowment (CARE) Fund to fund $1M in grants for research institutions in Washington state to unlock answers in ovarian cancer. This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine respectively, have each been recently awarded $300,000 in grants under the Rivkin Center and CARE Fund partnership for projects that aim to improve outcomes of the disease. 

The post $600,000 in Awards Against Ovarian Cancer for Fred Hutch and University of Washington Researchers appeared first on Life Science Washington.

]]> Seattle Startup Potato Lands $4.5M to Automate Science Experiments Using AI Assistants and Robots https://lifesciencewa.org/2025/04/22/seattle-startup-potato-lands-4-5m-to-automate-science-experiments-using-ai-assistants-and-robots/ Tue, 22 Apr 2025 15:19:44 +0000 https://lifesciencewa.org/?p=13434 With $4.5 million in fresh funding, Seattle-area startup Potato is sprouting big plans to disrupt scientific research with a fully automated experimental process. The 2-year-old company has released a platform that serves as an AI research assistant to help scientists generate hypotheses, create optimized protocols for conducting research, aid in writing papers for publication, and offer critiques […]

The post Seattle Startup Potato Lands $4.5M to Automate Science Experiments Using AI Assistants and Robots appeared first on Life Science Washington.

]]> With $4.5 million in fresh funding, Seattle-area startup Potato is sprouting big plans to disrupt scientific research with a fully automated experimental process.

The 2-year-old company has released a platform that serves as an AI research assistant to help scientists generate hypotheses, create optimized protocols for conducting research, aid in writing papers for publication, and offer critiques of journal articles.

The idea now is to go further and develop the technology needed for performing the actual experiments. They’ll start with computational research and move toward robotics capable of laboratory bench work.

The post Seattle Startup Potato Lands $4.5M to Automate Science Experiments Using AI Assistants and Robots appeared first on Life Science Washington.

]]> Benaroya Research Institute Awarded $11M Across Eight Grants in Second Half of 2024 to Predict, Prevent, Reverse, and Cure Immune System Diseases https://lifesciencewa.org/2025/04/07/benaroya-research-institute-awarded-11m-across-eight-grants-in-second-half-of-2024-to-predict-prevent-reverse-and-cure-immune-system-diseases/ Tue, 08 Apr 2025 02:04:21 +0000 https://lifesciencewa.org/?p=13316 Benaroya Research Institute announced eight research grants, totaling nearly $11.4M, awarded in the latter half of 2024. These included a $3.6M grant to investigate how a subset of regulatory cells are dysfunctional in controlling autoantibody production in patients with systemic lupus erythematosus. Another $3.8M grant will study Type 1 diabetes pathogenesis to guide timing and […]

The post Benaroya Research Institute Awarded $11M Across Eight Grants in Second Half of 2024 to Predict, Prevent, Reverse, and Cure Immune System Diseases appeared first on Life Science Washington.

]]> Benaroya Research Institute announced eight research grants, totaling nearly $11.4M, awarded in the latter half of 2024. These included a $3.6M grant to investigate how a subset of regulatory cells are dysfunctional in controlling autoantibody production in patients with systemic lupus erythematosus. Another $3.8M grant will study Type 1 diabetes pathogenesis to guide timing and selection of early therapies. Both are funded by the National Institutes of Health. 

The post Benaroya Research Institute Awarded $11M Across Eight Grants in Second Half of 2024 to Predict, Prevent, Reverse, and Cure Immune System Diseases appeared first on Life Science Washington.

]]> Ai2 and Google Cloud Join Cancer AI Alliance with a Total of $20M in Commitments https://lifesciencewa.org/2025/04/07/ai2-and-google-cloud-join-cancer-ai-alliance-with-a-total-of-20m-in-commitments/ Tue, 08 Apr 2025 02:03:11 +0000 https://lifesciencewa.org/?p=13313 The Allen Institute for AI (Ai2) is joining a high-profile national effort to accelerate cancer research using artificial intelligence, committing $10M in researcher time and technical expertise to the Cancer AI Alliance, a consortium led by the Fred Hutch Cancer Center. Google Cloud is also committing $10M in resources to the effort, planning to provide […]

The post Ai2 and Google Cloud Join Cancer AI Alliance with a Total of $20M in Commitments appeared first on Life Science Washington.

]]> The Allen Institute for AI (Ai2) is joining a high-profile national effort to accelerate cancer research using artificial intelligence, committing $10M in researcher time and technical expertise to the Cancer AI Alliance, a consortium led by the Fred Hutch Cancer Center. Google Cloud is also committing $10M in resources to the effort, planning to provide computing infrastructure and tools to help process large volumes of cancer data.

The post Ai2 and Google Cloud Join Cancer AI Alliance with a Total of $20M in Commitments appeared first on Life Science Washington.

]]> Aptevo Therapeutics Announces the Closing of $2.1M Registered Direct Offering https://lifesciencewa.org/2025/04/07/aptevo-therapeutics-announces-the-closing-of-2-1m-registered-direct-offering/ Tue, 08 Apr 2025 02:01:53 +0000 https://lifesciencewa.org/?p=13310 Aptevo Therapeutics, a biotech company developing new cancer treatments, raised approximately $2.1M through a stock and warrant sale. Aptevo intends to use the net proceeds from the proposed offering for the continued clinical development of its product candidates, working capital, and other general corporate purposes.

The post Aptevo Therapeutics Announces the Closing of $2.1M Registered Direct Offering appeared first on Life Science Washington.

]]> Aptevo Therapeutics, a biotech company developing new cancer treatments, raised approximately $2.1M through a stock and warrant sale. Aptevo intends to use the net proceeds from the proposed offering for the continued clinical development of its product candidates, working capital, and other general corporate purposes.

The post Aptevo Therapeutics Announces the Closing of $2.1M Registered Direct Offering appeared first on Life Science Washington.

]]> Health Sciences & Services Authority of Spokane County (HSSA) Doles Out Over $4M for Bioscience Economic Development https://lifesciencewa.org/2025/04/02/health-sciences-services-authority-of-spokane-county-hssa-doles-out-over-4m-for-bioscience-economic-development/ Wed, 02 Apr 2025 15:46:40 +0000 https://lifesciencewa.org/?p=13279 The Health Sciences & Services Authority of Spokane County awarded over $4.4M this winter to support bioscience innovation and expand healthcare access. Grants went to ten bioscience organizations and several groups addressing the region’s provider shortage. Established in 2007, HSSA advances public health and economic development in Spokane County.

The post Health Sciences & Services Authority of Spokane County (HSSA) Doles Out Over $4M for Bioscience Economic Development appeared first on Life Science Washington.

]]> The Health Sciences & Services Authority of Spokane County awarded over $4.4M this winter to support bioscience innovation and expand healthcare access. Grants went to ten bioscience organizations and several groups addressing the region’s provider shortage. Established in 2007, HSSA advances public health and economic development in Spokane County.

The post Health Sciences & Services Authority of Spokane County (HSSA) Doles Out Over $4M for Bioscience Economic Development appeared first on Life Science Washington.

]]> Cardiac Dimensions Lands $53M to Fund Research and Expansion of Heart Valve Technology https://lifesciencewa.org/2025/03/25/cardiac-dimensions-lands-53m-to-fund-research-and-expansion-of-heart-valve-technology/ Tue, 25 Mar 2025 20:29:33 +0000 https://lifesciencewa.org/?p=13226 Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors. Its total funding is more than $200 million. Cardiac Dimensions is targeting a condition called mitral valve regurgitation, which involves the leakage of blood through the heart’s mitral valve during the contraction of the left ventricle. […]

The post Cardiac Dimensions Lands $53M to Fund Research and Expansion of Heart Valve Technology appeared first on Life Science Washington.

]]> Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors. Its total funding is more than $200 million.

Cardiac Dimensions is targeting a condition called mitral valve regurgitation, which involves the leakage of blood through the heart’s mitral valve during the contraction of the left ventricle. The condition can lead to an enlarged heart and is associated with congestive heart failure.

The company’s Carillon Mitral Contour System is designed to tighten the leaky valve through a minimally invasive procedure.

The new funding positions the company “to continue our global commercial expansion of the Carillon therapy to improve the lives of patients with this debilitating disease,” said CEO and president Rick Wypych in a statement.

The post Cardiac Dimensions Lands $53M to Fund Research and Expansion of Heart Valve Technology appeared first on Life Science Washington.

]]> Curevo Vaccine Raises $110M in Series B for Shingles Vaccine https://lifesciencewa.org/2025/03/18/curevo-vaccine-raises-110m-in-series-b-for-shingles-vaccine/ Tue, 18 Mar 2025 22:24:37 +0000 https://lifesciencewa.org/?p=13152 Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110M in a Series B round. The fresh cash will help Curevo advance Phase 2 trials of amezosvatein, its shingles vaccine built from a non-living component of the virus and a proprietary adjuvant, a substance added to a shot to boost vaccine effectiveness. Shingles is a painful […]

The post Curevo Vaccine Raises $110M in Series B for Shingles Vaccine appeared first on Life Science Washington.

]]> Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110M in a Series B round. The fresh cash will help Curevo advance Phase 2 trials of amezosvatein, its shingles vaccine built from a non-living component of the virus and a proprietary adjuvant, a substance added to a shot to boost vaccine effectiveness. Shingles is a painful condition caused by reactivation of the virus that causes chicken pox.

The post Curevo Vaccine Raises $110M in Series B for Shingles Vaccine appeared first on Life Science Washington.

]]> Omeros Corporation Receives Commitment of Over $4M from NIDA for Further Development of the Company’s Program to Treat Cocaine Use Disorder https://lifesciencewa.org/2025/03/18/omeros-corporation-receives-commitment-of-over-4m-from-nida-for-further-development-of-the-companys-program-to-treat-cocaine-use-disorder/ Tue, 18 Mar 2025 22:21:00 +0000 https://lifesciencewa.org/?p=13148 Omeros Corporation announced that it has received a funding commitment from the National Institute on Drug Abuse (NIDA) for the upcoming year in the amount of $4.02M for clinical development of OMS527, to treat cocaine use disorder (CUD) by reducing or eliminating craving and relapse in patients with CUD. This grant will fund the Phase 1b […]

The post Omeros Corporation Receives Commitment of Over $4M from NIDA for Further Development of the Company’s Program to Treat Cocaine Use Disorder appeared first on Life Science Washington.

]]> Omeros Corporation announced that it has received a funding commitment from the National Institute on Drug Abuse (NIDA) for the upcoming year in the amount of $4.02M for clinical development of OMS527, to treat cocaine use disorder (CUD) by reducing or eliminating craving and relapse in patients with CUD. This grant will fund the Phase 1b clinical trial in patients with CUD to assess OMS527 safety and efficacy.

The post Omeros Corporation Receives Commitment of Over $4M from NIDA for Further Development of the Company’s Program to Treat Cocaine Use Disorder appeared first on Life Science Washington.

]]>